Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is an 18.2% decrease from the number of companies inspected in the previous quarter, when 11 companies received 11 inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. Both the Biologics and Devices sectors sectors tied for second most common type.
There were six companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Aarthun Enterprises, LLC | Food and Cosmetics | 09/08/2023 | Voluntary Action Indicated (VAI) |
Bergin Fruit Company, Inc. | Food and Cosmetics | 09/08/2023 | Voluntary Action Indicated (VAI) |
CSL Plasma, Inc. | Biologics | 07/13/2023 | No Action Indicated (NAI) |
Hawkins, Inc. | Food and Cosmetics | 08/29/2023 | No Action Indicated (NAI) |
LTS Therapy Systems, LLC | Devices | 09/20/2023 | No Action Indicated (NAI) |
Lacteos Mi Chalatenango, Inc. | Food and Cosmetics | 09/27/2023 | Voluntary Action Indicated (VAI) |
Medtronic, Inc. | Devices | 09/01/2023 | No Action Indicated (NAI) |
The American National Red Cross | Biologics | 07/28/2023 | No Action Indicated (NAI) |
Zen Baking Company | Food and Cosmetics | 07/20/2023 | No Action Indicated (NAI) |